D. Bumbacea (Bucharest, Romania), M. Sester (Homburg, Germany)
HIV/TB in Belarus
A. Astrauko, A. Skrahin, A. Skrahina (Minsk, Belarus)
|  |
Experience from implementation of collaborative TB/HIV activities in Republic of Macedonia – Where did we go wrong and where do we go from here?
D. Gudeva Nikovska, S. Talevski, H. Jankuloski (Skopje, Fyrom)
| |
Bacteriological profile in new cases of TB-HIV coinfected patients in Romania
M. Dede, C. Tudose, I. Pele, L. Lihatchi, E. Ibraim (Bucharest, Romania)
|  |
Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania
L. Lihatchi, C. Tudose, I. Pele, M. Dede, E. Ibraim (Bucharest, Romania)
| |
Multidrug-resistant TB in children with HIV infection in Romania
G. Murgoci, R. Murgoci, C. Marica, M. Tanasescu, G. Nini, H. Stavri, M. Mardarescu, M. Luminos (Bucharest, Arad, Romania)
| |
The risk of tuberculosis disease among HIV infected patients after 2 years of follow up
E. Dantes, O. C. Arghir, C. Cambrea, M. Man, E. Borgazi, S. Rugina (Constanta, Cluj, Romania)
| |
Primary drug resistance in HIV/TB patients
V. Zimina, I. Vasilyeva, A. Kravtchenko, F. Batirov, I. Viktorova (Moscow, Novokuznetsk, Russian Federation)
| |
The molecular-genetic methods in the express diagnostics of tuberculous pleurisy (PTB) in HIV-infected patients
V. Zhuravlev, K. Vladimirov, I. Vasilieva (St. Petersburg, Russian Federation)
| |
Value of third sputum specimen for microscopic detection of pulmonary tuberculosis in HIV infected patients
M. Marjani, P. Tabarsi, P. Baghaei, M. R. Masjedi, A. A. Velayati (Tehran, Islamic Republic Of Iran)
| |
Adverse effects of treatment in HIV-associated tuberculosis patients in Iran
P. Baghaei Shiva, P. Tabarsi, M. Marjani, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Prevalence of HIV seropositivity amongst tuberculosis patients at Rural Government Medical College Yavatmal – A five year prospective study
B. Bhadke, A. Surjushe (Yavatmal, India)
| |
Negative predictive value of TST and IGRA in anti-TNF treated patients
S. Campainha, T. Gomes, A. Carvalho, R. Duarte (Vila Nova de Gaia, Vila Real, Portugal)
| |
Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
M. Arias-Guillen, R. de Francisco, S. Riestra, A. Pando, J. J. Palacios, P. Escalante, I. Perez-Martinez, J. Belda, L. Molinos, M. García-Clemente, L. Rodrigo, A. Prieto, P. Casan (Oviedo, Spain; Rochester, United States Of America)
| |
The effect of anti TNF-alpha therapy on tuberculin skin test reaction
I. Hanta, S. Ozbek, O. Baydar, S. Kuleci (Adana, Turkey)
| |
The incidence of tuberculosis in patients taking anti TNF alpha therapy
C. Dogan, N. Kiral, S. Cömert, A. Fidan, B. Salepci, B. Caglayan (Istanbul, Turkey)
| |
Tumor nekrozis faktor-alfa blockers and tuberculosis – Analysis of the 6 years
S. Börekçi, B. Duman, N. Mazican, K. Tascilar, B. Müsellim, G. Öngen, V. Hamuryudan (Istanbul, Turkey)
| |
QuantiFERON-TB GOLD vs. TST methods of detection tuberculosis infection in rheumatoid arthritis patients with previously TNF α inhibitors treatment
Z. I. Fratila, I. Iovan, D. Vancea (Timisoara, Romania)
| |
Pulmonary tuberculosis (PT) in patients taking the TNF-a inhibitor inflixinab (INF)
P. Gavrilov, V. Zhuravlev, L. Archacova, S. Dolgikh (Saint-Petersburg, Russian Federation)
| |